Prof. AbdulGaniyu Ambali, the Vice
Chancellor of the University of Ilorin,
said the institution was collaborating
with the University of Wisconsin-
Madison, U.S. on stem cell research.
This is contained in a statement signed
by Mr Kunle Akogun, the Director,
Corporate Affairs Unit of the University
on Monday in Ilorin.
The statement said the vice chancellor
was a one week visit to the University of
Wisconsin-Madison, U.S.
It said that the collaboration with
Wisconsin-Madison would afford the
University a world class Stem Cell
Research Laboratory.
It said Ambali visited the Chancellor of
the University of Wisconsin-Madison,
Prof. Rebecca Blank, and some world
renowned experts on Stem Cell Research,
including Prof. Su-Chun Zhang.
“The VC also met with other renowned
stem cell researchers; Prof. Ralph
Albrecht, Prof. Jeff Johnson and Prof.
Tim Kamp,” it said.
“The VC had successfully secured
commitment from the University of
Wisconsin-Madison to partner UNILORIN
and the university would ensure the
structural development of the stem cell
research centre.
“The VC had stressed the commitment of
the University to the training of
technical staff on stem cell research
and related activities,” it said.
The statement noted that the University
of Ilorin would be responsible for the
provision of relevant regulations to
support the development of the stem cell
research centre.
It added that the university would also
provide security and accommodation for
all visiting staff of the University of
Wisconsin-Madison after they arrived in
Nigeria.
It noted that Ambali’s visit was in
furtherance of the Federal
Government’s mandate to the University
as the only University designated in the
North-central geopolitical zone for Bio-
Technology research.
“The VC reiterated the resolve of the
University to produce a critical mass of
health professionals with competencies
in management and control of common
communicable and non-communicable
diseases.
“We also want to translate research
findings and generate funds through
the commercialisation of key research
outputs and foster national, regional
and international linkages for
collaborative research in partnership,” it
said. [NAN]
Chancellor of the University of Ilorin,
said the institution was collaborating
with the University of Wisconsin-
Madison, U.S. on stem cell research.
This is contained in a statement signed
by Mr Kunle Akogun, the Director,
Corporate Affairs Unit of the University
on Monday in Ilorin.
The statement said the vice chancellor
was a one week visit to the University of
Wisconsin-Madison, U.S.
It said that the collaboration with
Wisconsin-Madison would afford the
University a world class Stem Cell
Research Laboratory.
It said Ambali visited the Chancellor of
the University of Wisconsin-Madison,
Prof. Rebecca Blank, and some world
renowned experts on Stem Cell Research,
including Prof. Su-Chun Zhang.
“The VC also met with other renowned
stem cell researchers; Prof. Ralph
Albrecht, Prof. Jeff Johnson and Prof.
Tim Kamp,” it said.
“The VC had successfully secured
commitment from the University of
Wisconsin-Madison to partner UNILORIN
and the university would ensure the
structural development of the stem cell
research centre.
“The VC had stressed the commitment of
the University to the training of
technical staff on stem cell research
and related activities,” it said.
The statement noted that the University
of Ilorin would be responsible for the
provision of relevant regulations to
support the development of the stem cell
research centre.
It added that the university would also
provide security and accommodation for
all visiting staff of the University of
Wisconsin-Madison after they arrived in
Nigeria.
It noted that Ambali’s visit was in
furtherance of the Federal
Government’s mandate to the University
as the only University designated in the
North-central geopolitical zone for Bio-
Technology research.
“The VC reiterated the resolve of the
University to produce a critical mass of
health professionals with competencies
in management and control of common
communicable and non-communicable
diseases.
“We also want to translate research
findings and generate funds through
the commercialisation of key research
outputs and foster national, regional
and international linkages for
collaborative research in partnership,” it
said. [NAN]
No comments:
Post a Comment